📢Nueva #NotaDePrensa sobre los resultados de la candidata a #vacuna de refuerzo de nueva generación para la #COVID19 que estamos desarrollando junto a
@GSK (@GSK_ES):
🔗https://t.co/xAg76B9A3m
Está basada a partir de la variante #Beta.
#SanofiEsVacunas
We’re pleased to share new data, which show that the Sanofi-GSK next-gen #COVID19 booster candidate demonstrated a strong immune response against variants of concern tested, including #Omicron, in adults primed with mRNA vaccinesWe’re pleased to share new data, which show that the Sanofi-GSK next-gen #COVID19 booster candidate demonstrated a strong immune response against variants of concern tested, including #Omicron, in adults primed with mRNA vaccinesWe’re pleased to share new data, which show that the Sanofi-GSK next-gen #COVID19 booster candidate demonstrated a strong immune response against variants of concern tested, including #Omicron, in adults primed with mRNA vaccinesWe’re pleased to share new data, which show that the Sanofi-GSK next-gen #COVID19 booster candidate demonstrated a strong immune response against variants of concern tested, including #Omicron, in adults primed with mRNA vaccinesWe’re pleased to share new data, which show that the Sanofi-GSK next-gen #COVID19 booster candidate demonstrated a strong immune response against variants of concern tested, including #Omicron, in adults primed with mRNA vaccines.
Nuevo súper-resumen de la pandemia (18 Feb 2022)
Evidencias científicas y contrastadas sobre el virus, vacunas, COVID19 larga y medicamentos. Basándome en datos y trabajos publicadas.
Sugiero llegar hasta el final del hilo. Hoy con resumen de imágenes top.
Agradezco RT.
First Omicron neutralization data from our lab using primary Omicron isolate from Tyrol with @AnnikaRoessler@LydiaRiepler @doctorflew and Dorothee von Laer @imed_tweets
With @GSK we’re announcing that the #booster study of our #COVID19 vaccine candidate demonstrates strong immune responses regardless of the primary vaccine received, with a good safety and tolerability profile.
Read more: https://t.co/yKMxT8jtNq
We’re proud to help bring & keep the pandemic under control by supporting the manufacturing of vaccines for 3 different companies on top of developing our own candidates. Sanofi will help produce @moderna_tx’s #COVID19 vaccine from September. https://t.co/KiLSzgVATl
#SanofiActs
Today we announce the start of the Phase 1/2 clinical trial for our #COVID19 mRNA vaccine candidate developed in partnership with @TranslateBio. This is an important step forward in helping protect people across the globe. https://t.co/vyL4vTd0Ta
#SanofiActs
Today we announce the initiation of the new Phase 2 trial for our #COVID19 recombinant vaccine candidate developed with @GSK, bringing us one step closer to combating the pandemic and protecting populations against this virus. https://t.co/bEcr3ppxKs
#SanofiActs
🏥La #vacunación es la medida más eficaz para prevenir la gripe
🔵Este año es más importante que nunca que las personas vulnerables se vacunen contra la gripe para evitar complicaciones y una sobrecarga en el sistema asistencial
#GripeYoMeVacuno
Following encouraging pre-clinical study results, today Sanofi and @GSK announce the start of the Phase 1/2 clinical trial for our #COVID19 vaccine. #SanofiActs
Mañana 9 de junio a las 1800 CET nueva sesión de #llightonvax3 sobre eventos cardiovasculares y respiratorios de #covid19 Regístrate en: https://t.co/tIIB4APpsb, y,conectate aquí: https://t.co/YwgKgqvtJk
💉¡Las #vacunas no solo te protegen a ti!
La inmunización frente a enfermedades infecciosas ayuda a evitar su propagación entre quienes no pueden recibir una #vacuna como:
👶Recién nacid@s
🙅Personas con contraindicaciones
#SanofiEsVacunas#LasVacunasFuncionan